Stuart Medical Inc., a small Owings Mills biotechnology company, received federal approval this week to begin marketing its first product, a medical device that simultaneously tests a patient's blood pressure and irregularities in heart rhythm.
The device, which is worn by patients for 24 hours, is an improvement over other devices on the market because it correlates the blood pressure with cardiac rhythm and can provide doctors with more information to use in diagnosing a patient's condition, company President James W. Bullock said.
The privately held company, founded in 1984, expects to be ready to ship its $25,000 SmartLINK System early next month but does not have any orders yet. Approval was just given by the U.S. Food and Drug Administration. The system includes two 8-ounce monitors that use computer technology and digital processing. The device stores the information, which is entered in a computer at a hospital or doctor's office.